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 i g  h  l  i  g  h  t  s
Neuroinﬂammatory  markers  and  microglia  were  compared  in young  mice  with  and  without  early  chronic  Pb exposure.
Mice  with  Pb levels  from  2.66  to 20.31  g/dL  had dose-dependent  reduction  of  cytokine  IL6.
Mice  with  Pb levels  from  2.66  to 20.31  g/dL  had dose-dependent  reduction  of  detectable  microglia.
No  evidence  of  increased  neuroinﬂammation  was  found.
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a  b  s  t  r  a  c  t
The  mechanisms  by  which  early  chronic  lead  (Pb)  exposure  alter  brain  development  have  not  been
identiﬁed.  We  examined  neuroimmune  system  effects  in  C57BL/6J  mice  with  Pb  exposure,  including
levels  that may  be common  among  children  in  lower  socioeconomic  income  environments.  Pups  were
exposed  via  dams’  drinking  water  from  birth  to  post-natal  day  28 to low,  high  or  no  Pb conditions.
We compared  gene  expression  of  neuroinﬂammatory  markers  (study  1);  and  microglial  mean  cell  body
volume  and  mean  cell body  number  in  dentate  gyrus,  and  dentate  gyrus  volume  (study  2).  Blood  Pb levels
in exposed  animals  at sacriﬁce  (post-natal  day  28)  ranged  from  2.66  to 20.31  g/dL.  Only  interleukin-icroglia
euroinﬂammation
eurotoxicity
entate gyrus
6  (IL6)  differed  between  groups  and  reductions  were  dose-dependent.  Microglia  cell  body  number  also
differed  between  groups  and  reductions  were  dose-dependent.  As compared  with  controls,  microglia  cell
body volume  was  greater  but highly  variable  in only  low-dose  animals;  dentate  gyri volumes  in  low-  and
high-dose  animals  were  reduced.  The  results  did  not  support  a model  of  increased  neuroinﬂammation.
Instead,  early  chronic  exposure  to Pb  disrupted  microglia  via  damage  to,  loss  of,  or lack  of proliferation
ping
istinaof  microglia  in the  develo
© 2013 Chr. Introduction
In children with no observable peripheral symptoms of Pb expo-
ure (“asymptomatic”), blood Pb levels as low as 2.5 g/dL have
Abbreviations: IBA-1, ionized calcium-binding adapter molecule 1; TNF-, tumor
ecrosis factor-alpha; IL-1, interleukin beta 1; IL-6, interleukin 6; IL-10, inter-
eukin 10; IFN-, interferon gamma; iNOS, inducible nitric oxide synthase; HO-1,
eme oxygenase; ROS, reactive oxygen species; -ALA, delta-aminolevulinic acid;
G,  dentate gyrus.
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been associated with, for example, lower IQ, reduced academic
achievement, and poorer memory, attention, motor dexterity
and problem-solving, suggestive of altered brain development
(Canﬁeld et al., 2003; Chiodo et al., 2004; Lanphear et al., 2005). In
mouse and rodent models, early chronic exposure to Pb resulted in
decreased memory, and abnormal motor and exploratory behavior
(Azzaoui et al., 2009; Kasten-Jolly et al., 2012; Leasure et al., 2008).
The mechanisms by which early chronic exposure to Pb alters brain
structure and function have not been identiﬁed.
Results from in vivo and in vitro studies have suggested that
Pb may  promote neurotoxicity by disrupting neuroimmune sys-
tem function (Kraft and Harry, 2011). The neuroimmune system
is comprised of microglial cells. Microglia protect brain tissue
Open access under CC BY-NC-ND license.through constant surveillance and scavenging of debris and for-
eign substances from the local environment (Schwartz et al., 2006);
microglia also facilitate neuronal activity, and interact function-
ally with astrocytes (Aloisi, 2001). During development, activated
 BY-NC-ND license.
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icroglia support and protect neurite development, guide synaptic
runing, and sculpt neural circuits (Paolicelli et al., 2011; Ransohoff
nd Cardona, 2010; Schafer et al., 2012). The critical neuroprotec-
ive role of microglia during early development is suggested by
he acute sensitivity of these cells to CNS changes, as indicated
y extremely rapid activation and proliferation response times
Dissing-Olesen et al., 2007). Microglia express IBA-1 thus IBA-1
ntibody is used in immunohistochemical preparations to label
icroglia in brain tissue.
Microglia are activated by various agents that trigger a sequence
f unique morphologic changes, including cell body enlargement.
ctivated microglia secrete an array of chemokines, eicosanoids,
roteases, complements, and cytokines including, for example,
NF-, IL-1, IL-6, IL-10, and IFN-. The inﬂuence of a given
ytokine is not singular, and at different times, might be pro-
r anti-inﬂammatory, and thus have neuro-protective or neuro-
estructive effects. Free radicals are increased by up-regulation of
NOS; and astrocytes simultaneously induce HO-1 which promotes
eduction of damaging ROS (Min  et al., 2006). During activa-
ion, microglia proliferate, and proliferation is stimulated by IL1-
nd TNF- (Mander et al., 2006). If microglial activation becomes
hronic, microglia synthesize neurotoxic levels of quinolinic acid
Espey et al., 1997) and promote extracellular glutamate concentra-
ions sufﬁcient to cause neuritic beading and cell death (Takeuchi
t al., 2005). Pro-inﬂammatory cytokines inhibit glutamate trans-
orters, which sustain abnormally high levels of extra-cellular
lutamate and thus, cyclic re-activation (Minami et al., 1991).
Findings from in vivo and in vitro studies show that Pb expo-
ure alters cellular functions in ways that might be expected to
romote chronic microglial activation. Pb accumulation in erythro-
ytes results in increased brain -ALA which enhances and prolongs
icroglial activation (Kaushal et al., 2007). Moreover, microglia
nteract functionally with astrocytes, via cytokines (Verderio and
atteoli, 2001), prostaglandins (Mohri et al., 2006) and nitric
xide synthase (Sola et al., 2002). Excess -ALA irreversibly inhibits
lutamate uptake by astrocytes, via alteration of the glutamate
ransporter GLT-1 (Emanuelli et al., 2003). Glutamate potentiates
strocytic increases in Ca2+ via activation of metabotropic glu-
amate receptors (Zonta et al., 2003). -ALA triggers astrocytic
a2+ waves which in turn activate microglia over large distances
Schipke et al., 2001).
Thus, by way of multiple mechanisms, free-ﬂoating Pb in brain
issue and increased brain -ALA might be expected to promote
euroimmune system disruption, chronic microglial activation and
icroglia proliferation, as evidenced by altered levels of pro- and
nti-inﬂammatory markers including TNF-, IFN-, IL6, IL10, iNOS
nd HO-1, increased microglial mean cell body number, and mean
ell body volume.
The aim of this study was to examine evidence of neuroimmune
nd brain structure differences in young C57BL/6J mice, with and
ithout chronic Pb exposure. In child studies, Pb exposure has been
ssociated with reduced short-term and working memory (see Sec-
ion 1), which are subserved by dentate gyrus (DG) (Niewoehner
t al., 2007), a sub-component of the hippocampal formation. In
odent models, low-level Pb exposure resulted in diminished recog-
ition memory (see Section 1) which is also subserved by dentate
yrus (Jessberger et al., 2009); moreover, DG microglia have been
hown to play a critical role in the maintenance of neural genesis
nd spatial learning and memory (Ziv et al., 2006).
In animals with and without Pb exposure, we  compared gene
xpression levels of neuroinﬂammatory markers (TNF-,  IFN-,
L6, IL10, HO-1, iNOS, and GRP78) in anterior (without hippocam-
us/DG) and posterior (with hippocampus/DG) brain regions. In a
eparate study, in animals with and without Pb exposure, we mea-
ured IBA-1 labeled microglia mean cell body number and mean
ell body volume; and volume of DG. We  predicted signiﬁcanttters 220 (2013) 44– 52 45
dose-dependent group differences on outcome measures. Only IL6
differed between groups and reductions were dose-dependent.
Microglia mean cell body number also differed between groups and
reductions were dose-dependent. Microglia mean cell body size
differed only among low-dose animals. As compared with controls,
dentate gyrus volumes in Pb-exposed animals were reduced.
2. Materials and methods
2.1. Animal methods
This study was carried out in strict accordance with the recommendations in
the Guide for the Care and Use of Laboratory Animals of the National Institutes
of  Health. The protocol was  approved and annually reviewed by the Institutional
Animal Care and Use Committee of the University of Texas at El Paso (NIH Assur-
ance #A3340-01). All surgery was performed under deep Avertin anesthesia and
all  efforts were made to minimize suffering. C57BL/6J (Jax Mice, Jackson Labora-
tory, Sacramento, CA) mice were bred and housed at the University of Texas at El
Paso  Biosciences Research Facility, Animal Vivarium, in clear polycarbonate cages
with wood chip bedding, 1 litter per container. Animals were maintained on a 12 h
light–dark schedule, vivarium temperature of 21 ± 2 ◦C, with ad libitum access to
food and water. Dams’ drinking water was tainted with 99.4% Pb acetate crystals
(Sigma–Aldrich). To maximally reduce animal stress, no invasive procedures were
conducted during the 28-day exposure period, litters were not culled, and studies
included males and females. Natural litters were exposed from birth to one of three
possible Pb doses: 0 ppm; 30 ppm; and 230 ppm (study 1) or 0 ppm; 30 ppm; and
330 ppm (study 2). For both studies, the dosing regimen was based on pilot studies
demonstrating that 30–40 ppm of Pb acetate in dams’ drinking water resulted in a
blood Pb level range similar to at least 65% of low-income children tested in our
child Pb exposure and behavior studies (unpublished data).
2.2. ICP-MS analysis of Pb
2.2.1. Instrumentation
Analysis by inductively coupled plasma mass spectrometry (ICP-MS) was per-
formed with an Agilent 7500ce ICP/MS equipped with an octopole reaction system
and a CETAC ASX-520 autosampler as previously described (Sobin et al., 2011).
Brieﬂy, samples were introduced to the plasma through a MicroMist U-series nebu-
lizer (Glass Expansion, Australia) and a double-pass quartz spray chamber (Agilent,
Santa Clara, CA). Instrument parameters were: carrier gas, 0.78 L/min; makeup gas,
0.15 L/min; RF power, 1420 W;  spray chamber temperature, 2 ◦C.
2.2.2. Sample treatment and analysis
Certiﬁed whole blood standards (Le Centre de Toxicologie du Quebec) were
analyzed to determine instrument reproducibility and validate quantitation. Ten
solutions were prepared for each of two standards (4.00 g/dL and 6.59 g/dL) and
each of those were analyzed three times by ICP-MS. Standard concentrations were
chosen to approximate low blood Pb values of children in this study. Blood stan-
dards were prepared as previously described (Sobin et al., 2011) (Agilent technical
note #5988-0533EN). Brieﬂy, 5.58 mL of water (18 M DI, Labconco WaterPro® PS
Station, Kansas City, MO)  was placed in a polypropylene tube into which 300 L
of  whole blood was  added, followed by addition of by 60 L of aqueous internal
standard solution (100 ppb each germanium, yttrium and terbium in 5% nitric acid,
Fisher Optima) and 60 L of aqueous 10 ppm gold in 3% hydrochloric acid (EMD
Chemicals) solution. The ﬁnal dilution was twenty-fold, the ﬁnal internal standard
concentration was 1 ppb and the ﬁnal gold concentration was  100 ppb. A six-point
external calibration curve was prepared from a Pb stock solution in 1% nitric acid.
ICP-MS standard solutions containing the elements in 2% nitric acid were obtained
from Inorganic Ventures (Christiansburg, VA). Samples were vortexed for a few sec-
onds prior to a 1 min  centrifugation at 2000 rcf and the supernatant analyzed by
ICP-MS. Blank solutions were analyzed after every three samples throughout the
analytical sequence and standard check solutions were analyzed ﬁve times, inter-
spersed through the sequence. All samples produced signals in excess of the limit
of  quantitation (i.e. ten-fold greater than the detection limit) for each analyte.
2.3. Gene expression studies
Brain tissue was removed immediately after sacriﬁce, snap frozen on dry ice and
stored at −80 ◦C until RNA extraction. Cerebellum was removed and the remaining
whole brain structure was cut (within 1 min) into anterior and posterior sections;
and sections were immediately homogenized (30 s). Anterior segments included at
least 90% of basal forebrain, striatum, ventral striatum and septum; and no more
than 10% of hippocampus, amygdala, thalamus, and hypothalamus. Posterior sec-
tions included at least 90% of the midbrain, hippocampus, amygdala, thalamus, and
hypothalamus; and no more than 10% of basal forebrain, ventral striatum, septum,
and  striatum.
2.3.1. RNA extraction
RNA was extracted using RiboPureTM Kit (Ambion). All procedures were
conducted at room temperature unless otherwise speciﬁed. Each section was
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omogenized individually with 400 L of TRI Reagent® . After homogenization,
00 L of chloroform was added, the mixture was vortexed (15 s), incubated (5 min),
nd  centrifuged at 12,000 × g (10 min). The aqueous layer was transferred to a micro-
entrifuge tube with 100 L of 100% ethanol, vortexed (5 s) and transferred to a
kit-supplied) ﬁlter cartridge and collection tube. The ﬁlter and collection tube were
entrifuged at 12,000 × g (1 min) to accomplish binding of the RNA to the ﬁlter. After
iscarding the ﬂow-through liquid, the ﬁlter was replaced and 250 L wash solu-
ion was  added to the tube was  and centrifuged at 12,000 × g (1 min), and repeated.
ith the ﬁlter was  in a new tube, 40 L of Elution Buffer was added to recover the
NA and incubated (2 min). After incubation, the tube was  centrifuged at 12,000 × g
90  s). DNase was  added to digest any remaining DNA. To each RNA sample, 1 L
f  10× DNase I Reaction Buffer and 1 L of DNase I Ampliﬁcation grade was  added
nd incubated (15 min). After incubation, 1 L of 25 mM EDTA solution was added
nd  the mixture heated to 65 ◦C (10 min). After treatment with DNase, RNA con-
entration was obtained using an ND-1000 (NanoDrop Technologies). RNA integrity
as  determined by 1.2% agarose gel. The RNA purity was  assessed by spectrometry
260/280 ratios).
.3.2. cDNA synthesis
cDNA synthesis was  conducted immediately after RNA extraction to reduce RNA
egradation using High Capacity cDNA Reverse Transcription Kit (Applied Biosys-
ems). Ten L of prepared master mix  was combined with 10 L of extracted RNA
n  a 0.2 mL tube, centrifuged brieﬂy, and loaded into a GeneAmp® PCR System 9700
hermal cycler (Applied Biosystems). Tubes containing cDNA were stored at −80 ◦C
ntil gene expression analysis.
.3.3. Gene expression analysis
Gene expression was  determined with quantitative real-time polymerase chain
eaction (QRT-PCR) and mRNA TaqMan® gene probes were used to quantitate
xpression of TNF-, INF-, IL-6, IL-10, iNOS, HO-1, and GRP78. The “housekeep-
ng” gene beta-actin was  used as the endogenous control for normalization of the
iomarker RNA quantities. A 96-well QRT-PCR plate was prepared containing an
mount of cDNA equivalent to 500 ng of RNA, 1 L TaqMan® probe, 10 L TaqMan®
niversal Master Mix, and an amount of nuclease free water that brought the total
olume in each well to 20 L. Filled plates were placed in an iCycler iQTM Optical
odule thermal cycler (BIO RAD) and the levels of each biomarker were measured.
ll  reactions were run in triplicate.
.3.4. Statistical analysis for gene expression studies
SAS version 9.1 software was used for all analyses. Data were entered and
hecked for accuracy and distribution properties prior to analysis. Normalized
xpression ratios were determined using the 2−CT (Livak) method (Livak and
chmittgen, 2001). Mean ratios of expression (“fold-change”) for each biomarker
ere compared using a 3 (group) × 2 (sex) × 2 (anterior/posterior section) general
inear model ANOVA. Type III sum of squares were used to determine statistically
igniﬁcant differences; post hoc tests of marginal means (“least square means”)
ere conducted for all signiﬁcant ANOVA models. When signiﬁcant group effects
ere found, linear regression analyses were used to test for dose–response relation-
hips.
.4. Immunohistochemistry
Mice were anesthetized with Avertin (Gaertner et al., 2008) immediately prior
o  sacriﬁce and perfused transcardially with 10% sucrose followed by phosphate-
uffered 4% paraformaldehyde. (A sucrose rather than saline pre-wash was  used
o  reduce cell distortion.) After removal, brains were post-ﬁxed in the same ﬁx-
tive overnight at 4 ◦C. Whole brains were randomly selected from each group
or immunohistochemical studies and included 10 controls, 10 low-dose, and 10
igh-dose brains. After cryoprotection in 0.1 M phosphate buffer (pH 7.4) contain-
ng 20% sucrose for up to 72 h (until sinking) at 4 ◦C, brains were rapidly frozen
n  isopentane pre-cooled to −75 ◦C with dry ice. All frozen brains were stored at
75 ◦C before sectioning. Serial cryostat sections were cut in a systematic–random
anner at an instrument setting of 40 m in the coronal plane through the whole
rain, including the brain stem and the cerebellum (Franklin and Paxinos, 1997).
our adjacent sets of four sections were collected into separate wells for staining,
enerating approximately 70 sections per set.
All sections of the ﬁrst set were processed for IBA-1 immunostaining with
ommercially available speciﬁc antibodies (given below). After inactivating the
ndogenous peroxidase activity with hydrogen peroxidase, sections were incu-
ated separately with avidin and biotin solutions (Vector Lab, Burlingame, CA)
o  block nonspeciﬁc binding of endogenous biotin. Sections were then incu-
ated free-ﬂoating for 43 h at 4 ◦C in 0.01 M phosphate-buffered saline (PBS,
H  7.4) containing 1% normal donkey serum, 0.3% Triton X-100 (Sigma, St.
ouis, MO)  and rabbit anti-Iba-1 IgG (1:6000, Cat.# 019-19741, Wako Chemicals
SA, Richmond, VA). Subsequently, the immune-reaction product was visualized
sing the avidin–biotin complex method of Hsu et al. (1981). In brief, sections
ere incubated in PBS containing normal donkey serum, Triton-X and biotin-SP-
fﬁniPure donkey anti-rabbit IgG (Jackson ImmunoResearch Labs, West Grove,
A)  for 1 h, and then in PBS containing avidin-biotinylated horseradish perox-
dase complex (Vectastin elite ABC kit, Vector Lab) for another hour. This wastters 220 (2013) 44– 52
followed by incubation of the sections for 5 min in 0.05 M Tris buffer (pH 7.2) con-
taining 0.03% 3′ ,3′-diaminobenzidine (Sigma) and 0.0075% H2O2. All steps were
carried out at room temperature except where indicated, and each step was
followed by washes in PBS. After thorough washes, all sections were mounted
on  gelatin-coated slides, and then were counterstained with FD cresyl violet
solutionTM (FD NeuroTechnologies). Following dehydration in ethanol and clear-
ing  in xylene, sections were coverslipped with Permount® (Fisher Scientiﬁc, Fair
Lawn, NJ).
2.5. Stereology
2.5.1. Anatomy
The upper and lower blades of the dentate gyrus (DG) contain three distinct
layers (molecular, granule and polymorphic). The C57BL/6 mouse DG extends from
coronal levels 64–93. The boundaries of the DG were deﬁned according to the Allen
Reference Atlas for the C57BL/6J mouse brain (Dong, 2008). This reference atlas was
used throughout data collection, and was consulted prior to DG demarcation of each
section.
2.5.2. Procedures
Prior to beginning data collection, for each subject, the total number of sec-
tions through the DG was  determined. A pilot study of two animals (one from
the 330 ppm exposure group and one from the control group) was  conducted
to  determine an optimal sampling scheme that would result in estimates of the
coefﬁcient of error (CE) at or below 0.15 while ensuring sampling efﬁciency. A
high stringency sampling approach was used in which sampling continued until
the mean CEs for all outcome variables were <0.15 (Table 2) (Gundersen et al.,
1999).
The estimation of DG microglia mean body cell volume, microglia mean body
cell  number, and DG volume, was assisted by StereologerTM software (Stereology
Resource Center, Chester, MD). The software was installed on a Dell Optiplex tower
computer and connected to a Nikon Eclipse E600 microscope (Nikon, Melville,
NY) ﬁtted with an X–Y–Z motorized stage controller (Prior Scientiﬁc, Rockland,
MA), linear encoder microcator (z-axis gauge) (Heidenhain, Schaumburg, IL), high
resolution color video camera (IMI Tech, Inc., Encinitas, CA) and .50 C-mount
(Nikon, Melville, NY). DG volume was estimated at 4× (Nikon Plan 4× 0.10);
DG microglia mean cell volume and mean cell number were estimated at 60×
(Nikon Plan APO 1.40 Oil). The camera image was processed with a high res-
olution video card and displayed on a 21 in. high resolution Dell monitor. One
experimenter (C.S.) collected all of the stereological data without knowledge of
the blood Pb level of each subject; the experimenter was not blind to treatment
group.
2.5.2.1. Dentate gyrus microglia mean cell number. An unbiased estimate of the num-
ber  of microglia in the DG was obtained using the optical fractionator method (West
et al., 1991) as reported previously for quantiﬁcation of total number of microglia in
mouse models of aging and neuropathology (Mouton et al., 2002). For each section
the  software randomly sampled virtual 3-D counting frames (disector) at 60× mag-
niﬁcation with a 2 m guard area. Using thin-focal plane optical scanning, microglia
were counted when they fell within the central depth of the counting frame and/or
touched the inclusion lines. The total number of microglia was estimated with
the  following formula: Nobj = Q− × 1/SSF × 1/ASF × 1/TSF; where Q− = sum of the
objects sampled; SSF = sampling interval; ASF = total area sampled/total area on all
sampled sections; and TSF = the height of the sample/total section thickness.
2.5.2.2. Dentate gyrus mean cell volume. For each frame, mean cell volume was
quantiﬁed on microglia counted with the disector probe.
2.5.2.3. Dentate gyrus volume. The dentate gyrus reference volume (V(ref))
was  determined at 4× magniﬁcation using the Cavalieri-point counting
approach (Gundersen and Jensen, 1987): V(ref) = ([k × t] ×
∑
P × [a(p)/M2]); where:
k  = sampling interval; t = post-processing section average thickness; and thus
[k  × t] = distance between planes;
∑
P = sum of points counted; [a(p)/M2] = test grid
area per point (m2) divided by the magniﬁcation factor squared. Examples of
microglia images are provided in Fig. 4.
2.5.2.4. Statistical analysis of stereological results. SAS Version 9.2 statistical software
was  used for all analyses. All data were entered and checked for accuracy and distri-
bution properties prior to analysis. No extreme outliers were identiﬁed, and all data
were included for analysis. Coefﬁcient of error values and section thickness, and DG
microglia mean cell volume, DG microglia mean cell number, and DG volume were
compared using a 3 (group) × 2 (sex) general linear model ANOVA. Type III sum of
squares were used to determine statistically signiﬁcant differences; post hoc tests
of marginal means (“least square means”) were conducted for all signiﬁcant ANOVA
models. When signiﬁcant group effects were found, linear regression analyses were
used to test the possible dose–response relationship between blood Pb level and the
outcome variable.
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Table 1
Mean (SEM) of relative quantiﬁcation in fold-change of gene expression, in anterior and posterior brain of C57BL/6J mice at PND 28 following chronic Pb exposure.
Anterior brain (without hippocampus/DG) Posterior brain (with hippocampus/DG)
0 ppm 30 ppm 230 ppm 0 ppm 30 ppm 230 ppm
TNF 1.05 (0.12) 1.18 (0.30) 1.30 (0.15) 1.00 (0.15) 1.07 (0.20) 1.41 (0.41)
IFN  0.83 (0.05) 1.28 (0.30) 1.11 (0.33) 0.57 (0.05) 1.08 (0.29) 0.87 (0.34).
IL6  2.33 (0.27) 1.72 (0.18) 1.47 (0.29) 1.54 (0.25) 1.23 (0.10) 0.87 (0.20)*
IL10 1.25 (0.14) 1.69 (0.20) 1.27 (0.19) 0.89 (0.11) 1.14 (0.13) 1.20 (0.37)
GRP78  1.61 (0.22) 1.63 (0.23) 1.72 (0.25) 1.54 (0.30) 1.68 (0.19) 1.88 (0.51)
HO-1  1.25 (0.21) 1.14 (0.11) 1.13 (0.14) 1.15 (0.43) 0.85 (0.38) 1.33 (0.46)
iNOS  0.86 (0.07) 1.14 (0.17) 1.06 (0.14) 1.20 (0.28) 0.92 (0.19) 1.42 (0.50)
* ANOVA p < 0.01.
Table 2
ANOVA testing for group differences in microglia mean cell body volume and microglia mean cell body number in dentate gyrus, and dentate gyrus volume, in young C57BL/6J
mice  with and without Pb exposure (N = 30).
Source of variation df Sum of squares Mean square F p
Microglia volume (m3)
Group 2 18129.30 9064.65 12.01 <0.01
Error  27 20370.47 754.46
Microglia number
Group 2 43,925,346 21,962,673 24.49 <0.01
Error  27 24,216,482 896,907
Dentate gyrus volume (mm3)
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microglia mean cell body volume of the 30 ppm Pb exposure group
was signiﬁcantly larger (154.92 + 40.35; 95% C.L. 137.10–172.74),
t = 3.30, p < 0.01. As compared with controls, the microglia mean
cell body volume of the 330 ppm Pb exposure group (96.09 + 14.49;
Table 3
Coefﬁcient of error (CE) estimates for the measurement of microglia mean cell body
volume and microglia mean cell body number in dentate gyrus, and dentate gyrus
volume, in young C57BL/6J mice with and without Pb exposure, N = 30.
Microglia mean
cell body
volume
Microglia mean
cell body
number
Dentate gyrus
volumeGroup 2 4.64 
Error  27 5.45 
. Results
.1. Neuroinﬂammatory markers (study 1)
We  analyzed blood samples and brain tissue from N = 16
10 male) C57BL/6J mice exposed from birth to PND 28, to
ne of three Pb exposure treatments via dams’ drinking water:
0 ppm, n = 6 (4 males); 230 ppm, n = 4 (2 males); 0 ppm, n = 6
3 males). The mean (SD) blood Pb levels of mice at sacriﬁce
PND 28) were: controls = 0.22 g/dL (0.13); 30 ppm = 4.12 g/dL
1.49); 230 ppm = 10.31 g/dL (2.42). Gene expression levels were
etermined with real-time quantitative-polymerase chain reac-
ion (QRT-PCR). The 2−CT (Livak) method (Livak and Schmittgen,
001) was used to quantify differences in gene expression rela-
ive to the external control. The fold-change for each probe was
ompared using 3 (group) × 2 (sex) × 2 (anterior/posterior section)
NOVA; signiﬁcant models were further tested with post hoc tests
f marginal means (“least square means”). The ampliﬁcation ratios
or biomarkers and beta-actin were 0.95–0.97.
The relative quantiﬁcation values in fold-change for each
iomarker are given for anterior brain and posterior brain (Table 1).
NOVA analyses revealed signiﬁcant group differences only for
L6, model F11,19 = 3.52, p < 0.01; type III SS for group main effect,
 = 6.48, p < 0.01; and for anterior/posterior main effect, F = 13.82,
 < 0.01; no main effect for sex; no signiﬁcant interactions.
Tukey’s post hoc analyses revealed signiﬁcant differences
p < 0.01) between controls and 30 ppm group (1.93 + 0.14 vs.
.29 + 0.18); and between controls and 230 ppm group (1.93 + 0.14
s. 1.17 + 0.17); and no signiﬁcant difference in IL6 expression
etween 30 ppm and 230 ppm groups.
Tukey’s post hoc analyses conﬁrmed a signiﬁcant difference,
 = 4.12, p < 0.01, between IL6 expression in anterior vs. posterior
rain (1.74 + 0.13 vs. 1.18 + 0.13). Regression analyses predicting
L6 fold-change from blood Pb level were signiﬁcant, suggesting small dose–response effect. In posterior brain, as blood Pb level
ncreased, IL6 decreased, adj r2 = 0.21; IL6 = 1.52 + (−0.06 × blood Pb
evel). A small signiﬁcant association was also observed in anterior
rain, adj r2 = 0.24; IL6 = 2.23 + (−0.08 × blood Pb).2.32 11.50 <0.01
2.02
3.2. Stereological analysis of microglia and dentate gyrus volume
(study 2)
Mean cell body volume, mean cell body number and den-
tate gyrus volume was quantiﬁed in brain tissue from N = 30 (17
males) C57BL/6J mice exposed from birth to PND 28, to one of
three Pb exposure treatments via dams’ drinking water: 30 ppm,
n = 10 (6 males); 330 ppm, n = 10 (4 males); or 0 ppm, n = 10 (7
males). The mean (SD) blood Pb levels of mice at sacriﬁce (PND
28) were 30 ppm = 3.42 g/dL (0.71); 330 ppm = 13.84 g/dL (2.86);
controls = 0.03 g/dL (0.01). Coefﬁcient of error estimates for the
measurement of dependent variables are shown in Table 3. The
distributions of group means, standard deviations, minimum and
maximum values for microglia mean cell body volume, microglia
mean cell body number, and volume of DG are shown in Figs. 1–3.
3.2.1. Microglia mean cell body volume
Two-way ANOVA (group × sex) indicated a statistically signiﬁ-
cant difference among the groups (F2,27 = 12.01; p < 0.01; Table 1)
with no main effect for sex; and no interaction.
Further analysis with Tukey’s post hoc tests revealed that, as
compared with controls (114.39 + 20.62; 95% C.L. 96.57–132.21),0 ppm (controls, n = 10) 0.045 (0.006) 0.108 (0.009) 0.091 (0.012)
30  ppm (n = 10) 0.036 (0.011) 0.129 (0.016) 0.109 (0.013)
330 ppm (n = 10) 0.052 (0.010) 0.134 (0.012) 0.094 (0.020)
All  groups 0.044 (0.009) 0.124 (0.012) 0.098 (0.015)
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Fig. 1. Microglia mean cell body volume in m3 by exposure group in dentate
gyrus. The box plots show the distributions of microglia mean cell body volumes in
young C57BL/6J mice exposed to 0 ppm (n = 10), 30 ppm (n = 10), or 330 ppm (n = 10)
Pb acetate from birth to PND 28 (N = 30). Box plots show the inter-quartile range
(25–75th percentile); bars indicate the location of maximum fence values (±1.5x
the IQR); central diamond shows the mean; central line shows the median; extreme
values are shown with circles. Comparison bars between groups show p values from
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Fig. 3. Dentate gyri volumes in mm3 by exposure group. The box plots show the
distributions of dentate gyri volumes by exposure group in young C57BL/6J mice
exposed to 0 ppm (n = 10), 30 ppm (n = 10), or 330 ppm (n = 10) Pb acetate from birth
to  PND 28 (N = 30). Box plots show the inter-quartile range (25–75th percentile);
bars indicate the location of maximum fence values (±1.5x the IQR); central dia-
mond shows the mean; central line shows the median; extreme values are shown
with circles. Comparison bars between groups show p values from post hoc tests ofost hoc tests of marginal (“least square”) means. Group difference conﬁdence limits
re provided in the text.
5% C.L. 78.27–113.91) did not differ signiﬁcantly, t = 1.49, p = 0.15,
nd thus a dose–response effect was not observed.
.2.2. Microglia mean cell body number
Two-way ANOVA (group × sex) indicated a statistically signiﬁ-
ant difference among the groups (F2,27 = 24.49; p < 0.01; Table 1)
ith no main effect for sex; and no interaction.
Tukey’s post hoc tests revealed that, as compared with con-
rols (7116 + 1363; 95% C.L. 6501–7730), the microglia mean cell
ody number of the 30 ppm Pb exposure group was signiﬁcantly
ecreased (5274 + 808; 95% C.L 4660–5889), t = −4.35, p < 0.01.
ig. 2. Microglia mean cell body number by exposure group in dentate gyrus. The
ox  plots show the distributions of microglia mean cell body numbers by exposure
roup in young C57BL/6J mice exposed to 0 ppm (n = 10), 30 ppm (n = 10), or 330 ppm
n  = 10) Pb acetate from birth to PND 28 (N = 30). Box plots show the inter-quartile
ange (25–75th percentile); bars indicate the location of maximum fence values
±1.5x  the IQR); central diamond shows the mean; central line shows the median;
xtreme values are shown with circles. Comparison bars between groups show p
alues from post hoc tests of marginal (“least square”) means. Group difference
onﬁdence limits are provided in the text.marginal (“least square”) means. Group difference conﬁdence limits are provided in
the text.
Similarly, as compared with controls, the microglia mean cell
body number of the 330 ppm Pb exposure group was signiﬁ-
cantly decreased (4184 + 423; C.L. 3569–4789), t = −6.92, p < 0.01.
Microglia mean cell body number of the 30 ppm and 330 Pb expo-
sure group differed signiﬁcantly, t = −2.57, p = 0.02, suggesting a
dose response relationship between DG microglia number and
blood Pb level.
Thus, from 30 animals, we  attempted to predict DG microglia
mean cell body number from blood Pb levels using simple linear
regression analysis. A moderate linear association was suggested.
The slope of the regression line was  signiﬁcantly less than zero,
suggesting that as blood Pb level increased, the number of
DG microglia decreased (slope = −170; 95% C.L. −240 to −101;
t28 = −5.02; p < 0.01; DG microglia = 6505 + (−170 × blood Pb level);
adj r2 = 0.47).
3.2.3. Dentate gyrus volume
Two-way ANOVA (group × sex) indicated a statistically signiﬁ-
cant difference among the groups (F2,27 = 11.50; p < 0.01; Table 1);
with no main effect for sex, and no interaction.
Tukey’s post hoc tests revealed that, as compared with con-
trols (0.38 mm3 + 0.06; 95% C.L. 0.35–0.41), the DG volume means
of the 30 ppm Pb exposure group (0.29 mm3 + 0.03; 95% C.L
0.26–0.32), (t = −4.65, p < 0.01); and the 330 ppm Pb exposure group
(0.31 mm3 + 0.04; C.L. 0.28–0.34), (t = −3.35, p < 0.01); were sig-
niﬁcantly decreased. DG volumes of the 30 ppm and 330 ppm
Pb exposure groups were not statistically signiﬁcant (t = −1.30,
p = 0.20) suggesting that the relationship between blood Pb level
and DG volume was not linear.
To examine whether the microglial cell loss might account
for reduced DG volume, from 30 animals, we attempted to
predict DG volume from microglial cell body number using
simple linear regression analysis. A small linear association was
suggested. The slope of the regression line was signiﬁcantly
greater than zero, suggesting that as microglial cell body num-
ber increased, DG volume increased (slope = 0.000019 mm3;
95% C.L. 0.00000564–0.00003169 mm3; t28 = 6.12; p < 0.01;
Y = 0.22 mm3 + (0.00019 mm3 × X); adj r2 = 0.20).
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Fig. 4. Examples of microglia in dentate gyrus. These images show examples of
microglia in the dentate gyrus polymorph layer, coronal level 89 captured at 40×
(Nikon Plan Oil). The sampling frames are from: (A) a control (0 ppm) animal, blood
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tb  0.02 g/dL; (B) a 30 ppm animal, blood Pb level = 2.64 g/dL; and (C) a 330 ppm
nimal, blood Pb level = 13.45 g/dL. Animals were exposed from birth to PND 28
ia  dams’ drinking water.
. Discussion
.1. Overview
Previous research suggested that via diverse mechanisms Pb
xposure promotes neuroimmune disruption, and perhaps chronic
icroglial activation and microglial proliferation (Kraft and Harry,
011). Neuroimmune system changes following early chronic
xposure to Pb and blood levels between 2 g/dL and 20 g/dL
ave rarely been examined. Hippocampus/DG regions have been
mplicated in animal models (Azzaoui et al., 2009; Kasten-Jolly
t al., 2012; Leasure et al., 2008) and clinical studies of asymp-
omatic Pb exposed children (Canﬁeld et al., 2003; Chiodo et al.,tters 220 (2013) 44– 52 49
2004; Lanphear et al., 2005). Thus, we compared neuroinﬂam-
matory markers in anterior (without hippocampus) and posterior
(with hippocampus) brain sections; and we compared the vol-
ume  and number of neuroimmune cells in the DG. We  predicted
dose-dependent changes in gene expression of neuroinﬂammatory
biomarkers consistent with heightened microglial activation, and
increased microglial mean cell body volume and number. Under-
standing whether dose–response relationships exist between Pb
and outcome variables can be critical for understanding the nature
of possible mechanisms of action, and also for comparison in
subsequent studies that aim to replicate and reﬁne the current
ﬁndings. We  also measured DG volume to examine evidence
of neurodegeneration. The range of blood Pb levels achieved in
the 30 ppm exposure groups (study 1 = 2.86–6.78 g/dL; study
2 = 2.48–4.65 g/dL) replicated the blood Pb levels of approxi-
mately 65% of low-income children tested in our child Pb exposure
studies (unpublished data). Signiﬁcant differences between expo-
sure groups on outcome variables were found, but were not
suggestive of heightened microglial activation.
4.2. No evidence for increased neuroinﬂammation in Pb exposed
animals
Increased neuroinﬂammatory response in Pb exposed animals
was discounted by the absence of group effects for ﬁve of six
neuroinﬂammatory markers examined, including TNF-, IFN-,
IL10, iNOS and HO-1. Only IL6 differed in Pb exposed animals,
and a dose-dependent reduction was observed. Astrocytes absorb
free-ﬂoating brain Pb; within astrocytes 78 kDa glucose-regulated
protein (GRP78) sequesters Pb, a process which inactivates this
chaperone protein (Lindahl et al., 1999) and results in decreased
release of IL6 (White et al., 2007). IL6 serves neuroprotective and
neuroadaptive functions (Gruol et al., 2011; Inomata et al., 2003)
thus reduced IL6 may  suggest one source of increased neurotoxic
vulnerability in Pb exposed animals. Reduction of astrocytic IL6
release reduces functional coupling of microglia and astrocytes,
and disrupts regulation of microglia by astrocytes (Hinkerohe et al.,
2005). Reduction of IL6, with no changes observed in TNF-, IFN-,
IL10, iNOS and HO-1, suggested that IL6 differences were not linked
to heightened neuroinﬂammation.
4.3. Broad variability of microglial volume in low-exposure
animals
Microglia mean cell body volume of animals from the 30 ppm
group with blood Pb levels between 2.48 g/dL and 4.65 g/dL
exceeded that of the controls by 40.53 m3, however the larger
group mean was  derived from an extremely broad range of cell
sizes in the low-dose animals (Fig. 1) that was unique to the low-
dose animals. Morphological studies of qualitative cell features are
needed to examine structural sources of these observed volumetric
differences. (Microglia mean cell body volume of the 330 ppm ani-
mals did not differ signiﬁcantly from controls. This will be discussed
further below.)
4.4. Reduced numbers of detectable microglia in low- and
higher-exposure animals
During activation microglia proliferate. With regard to DG
microglia number, counter to our hypothesis, as compared with
controls the microglia mean cell body number of the 30 ppm expo-
sure group was signiﬁcantly decreased (1842 fewer cells). In the
330 ppm exposure group, as compared with controls, the decrease
was even greater (2932 fewer cells), and differed signiﬁcantly from
the 30 ppm exposure group. Regression analysis conﬁrmed that the
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ffects were dose-dependent and suggested that for each one unit
g/dL) increase in blood Pb, DG microglia decreased by 170 cells.
There are several possible sources of fewer detectable IBA-1
abeled microglia in Pb-exposed animals. IBA-1 is present in all
ormal microglia and it is up-regulated during activation. IBA-1
ritically regulates membrane rufﬂing, cell motility and phago-
ytosis (Deininger et al., 2002; Ito et al., 1998). Fewer detected
BA-1 labeled microglia in Pb exposed animals could result from
isrupted production of IBA-1 in microglia (which in turn would
isable normal microglial cell function). Determining whether the
ndings reﬂect fewer normally functioning microglia, rather than
eduction of total microglial cells, requires further study. Also of
ote, whether IBA-1 is expressed exclusively by microglia has
een recently questioned. For example, one study of rat brain
uggested that other types of macrophages also express IBA-1
ncluding meningeal, supra ependymal, and vascular stromal cells
Kirik et al., 2011). Of these, stromal cells may  be found in dentate
yrus, and their morphology differs from that of microglia. This is
 consideration for future studies of neuroimmune function and Pb
xposure that examine brain regions likely to include these types
f macrophages.
Another explanation concerns proliferation mechanisms. Stud-
es have suggested that the P2X7 receptor is critical for microglial
roliferation during activation (Monif et al., 2010). Future studies
ould examine the effects of brain Pb and/or increased -ALA on
2X7 and thus proliferation.
The effects of Pb on microglia progenitors also should be consid-
red. Microglia are derived from hematopoietic stem cells in bone
arrow. Some of these stem cells differentiate as monocytes and
urther differentiate as microglia in the brain (Ritter et al., 2006).
b is sequestered in bone marrow. Studies are needed to examine
hether Pb in bone marrow disrupts critical replenishment of the
ematopoietic daughter cell pool, thus reducing the migration of
dequate progenitor cell numbers to the brain.
Finally, reduced numbers of IBA-1 labeled microglia may  sug-
est that early chronic Pb exposure resulted in direct destruction
f microglia. Astrocytes are typically noted to be the brain’s “lead-
ink.” The primary role of microglia however is to scavenge the
rain for debris; further studies are needed to examine whether
icroglia are destroyed by scavenged Pb particles.
Very recent studies have illuminated the critical role of microglia
n brain development (Paolicelli et al., 2011). Additional studies are
eeded to examine whether pruning abnormalities are evident in
ice with early chronic Pb exposure, and whether reduced num-
ers of functional microglia in lead exposed animals compromises
he neuroimmune response system.
.5. Reduced volume of dentate gyri in Pb-exposed animals
Given the potential neurodegenerative effects of disrupted neu-
oimmune function, we also examined DG volume. As compared
ith controls, DG volume in both exposure groups was signiﬁ-
antly decreased, and exposure groups did not differ signiﬁcantly.
ecause both exposure groups received chronic dosing, the lack of
ifference between low and higher exposure groups with regard
o DG volume suggested that the chronicity of exposure may  have
ad more neuropathological signiﬁcance than the amount of Pb to
hich the mice were exposed. Studies are needed to compare DG
olume differences in cases of chronic versus acute exposure, to test
ow chronicity of exposure inﬂuences the effects of early chronic
b exposure on brain structure volume.
Reduced DG volume could suggest either developmental delayf structure volume, or tissue deterioration in Pb-exposed animals.
he lack of difference between low and higher Pb exposure groups
uggested that whatever qualitative differences may  exist between
arly chronic Pb exposure levels, delay and/or deteriorative effectstters 220 (2013) 44– 52
on development of dentate gyrus volume are not distinguishable
in animals with low and higher exposures. We  also examined the
association between microglia number and DG volume, and regres-
sion analysis suggested that microglia number accounted for only
a small amount of variation in DG volume, thus the volumetric
differences are likely attributable to other sources, for example,
disrupted integrity and/or numbers of other types of glia and/or
neurons. Astrocytes are functionally linked to microglia (Section
1) and are far more abundant than microglia. Studies are needed
to determine whether damage to astrocytes following perturba-
tion of microglia account for DG volume reduction in chronic lead
exposure.
Diminished DG volume has implications for learning and mem-
ory during development. Just as importantly, the DG is one of the
few brain regions in which neurogenesis occurs throughout adult-
hood (Ming and Song, 2005). Thus, delay of development in DG
volume, and/or loss of DG volume during development, would be
expected to impact the acquisition of early neurocognitive func-
tions, while also impairing brain resilience in later life. Further
studies are needed to examine effects on the aging brain of early
chronic exposure to Pb.
4.6. Summary
The ﬁndings suggested neuroimmune system disruption, but
not chronic neuroinﬂammation and heightened microglial activa-
tion. Furthermore, microglial mean cell body volume differences
in animals with lowest vs. higher Pb chronic exposure suggested
qualitatively different types of neuroimmune disruption in these
groups. Further studies of cytokine levels, in combination with
cytokine gene expression, could be useful for conﬁrming these
ﬁndings. Studies are needed to examine the independent effects
on microglia of local Pb concentrations and increased -ALA, at
lowest and higher chronic and acute doses, and using additional
microglial activation markers such as CD45, CD68, and F4/80. Inves-
tigating concentrations of Pb in brain and increased brain -ALA
as distinct neurotoxic triggers may  help differentiate their roles in
effect pathways. It is also important to examine the effects of early
chronic lowest and higher levels of Pb concentrations on progen-
itor cells. We  selected DG as the target structure in these studies
because of its critical role in learning and memory, and its role in
neurogenesis during adulthood. Additional studies are needed to
test for evidence of neuroimmune disruption in other brain regions
implicated by results from the child and animal lead exposure lit-
erature, including for example, caudate putamen and substantia
nigra.
5. Conclusions
Mice chronically exposed to Pb from birth to PND 28, with blood
Pb levels from 2.48 to 20.31 g/dL, had dose-dependent reduction
of IL6 gene expression in posterior and anterior brain, signiﬁ-
cantly less IL6 in posterior brain, dose-dependent reduction in DG
microglia mean cell body number, and reduced DG volume. Chronic
Pb exposure promoted microglia with broad variability in mean cell
body volume, only in animals with blood levels between 2.48 g/dL
and 4.65 g/dL, and with no increases in inﬂammatory markers.
The ﬁndings lend initial support for neuroimmune system disrup-
tion, but not neuroinﬂammation, as one source of abnormal brain
development with chronic developmental exposure to Pb.Conﬂict of interest statement
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